Antiamnesic evaluation of C. phlomidis Linn. bark extract in mice

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 44, Issue 4, 2008, Pages 717-725

  Joshi, Hanumanthachar ^a   Megeri, Krupa ^b  

^a S E T S COLLEGE OF PHARMACY   (India)

^b KARNATAK UNIVERSITY   (India)

Author keywords

Acetyl cholinesterase; Alzheimer's disease; Clerodendron phlomidis; Nootropic agent

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; CLERODENDRON PHLOMIDIS EXTRACT; DIAZEPAM; NOOTROPIC AGENT; PIRACETAM; PLANT EXTRACT; SCOPOLAMINE; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARK; BEHAVIOR; BRAIN LEVEL; CLERODENDRON PHLOMIDIS; COGNITIVE DEFECT; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HYPERACTIVITY; HYPOTHERMIA; LEARNING; LETHARGY; LONG TERM MEMORY; MALE; MAZE TEST; MEDICINAL PLANT; MEMORY; MORTALITY; MOUSE; NONHUMAN; PTOSIS; SEDATION; SHORT TERM MEMORY; SWISS WEBSTER MOUSE;

EID: 59649128296     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322008000400019     Document Type: Article

References (43)

1. NATIONAL INSTITUTE OF AGING-NATIONAL INSTITUTES OF HEALTH. Progress Report on Alzheimer's disease: Taking the next steps. Washington: National Institutes of Health, 2000. p.1154-1156.
2. BHATTACHARYA, S.K.; BHATTACHARYA, A.; KUMAR, A.; GHOSAL, S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. PTR, Phytother. Res., v.14, n.p.174-179, 2000.
3. CAHIL, L.; BRIONI, J.; IZQUIERDO, I. Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci., v.21, n. p.294-299, 1998.
4. CASELLI, R. J.; BEACH, T.J.; YAARI, R.; REIMAN, E, M. Alzheimer's disease-a century later. J. Clin. Psychiatry, v.67, n.11, p.1784-800, 2006.
5. CHOPRA, R.N. Glossary of Indian medicinal plants, CSIR, New Delhi, 1956, 162-164p.
6. DHINGRA, D.; MILIND, P.; KULKARNI, S.K. Memory enhancing activity of Glycyrrhiza glabra in mice. J. Ethnopharmacol., v. 1, n. p. 361-365, 2004.
7. DOODY, R.S.; STEVENS, J.C.; BECK, R.N.; DUBINSKY, R.M.; KOYE, J.A.; GWYTHER, L. Practice parameters: Management of dementia (an evidence based review)-report of the quality standards subcommittee of the American Academy of Neurology. Neurology, v.56, n. p. 1154-1166, 2001.
8. ELDER, G.A.; DE GASPERI, R.; GAMA SOSA, M. A. Research update: neurogenesis in adult brain and neuropsychiatric disorders. Mt. Sinai J. Med., v. 73, n.7, p. 731-740, 2006.
9. ELLMAN, G.L.; COURTNEY, K.D.; VALENTINO, A.J.; FEATHERSTONE, R.M. A new and rapid colourimetric determination of acetylcholinestrase activity. Biochem. Pharmacol., v.7, n. p. 88-95, 1961.
10. FRANCESCO, C.; AUDREY, M.N.; DAVID, R.M.; ERCOLANO, M.;PAOLO, P. Evidence based research in complementary and alternative medicine II: Treatment of patients with Alzheimer's disease. eCAM, v.3, n.4, p. 411-424, 2006.
11. GANDIA, L.; ALVAREZ, R.M.; HERNANDEZ-GUIJO, J.M.; GONZDEZ-RUBIO, J.M.; DE PASCULA, R.; ROJO, J.;TAPIA, L. Anticholinesterases in the treatment of Alzheimer's disease. Rev. Neurol., v. 27, n.1, p. 471-477, 2006.
12. GELDMACHER, D.S. Alzheimer's disease: current pharmacotherapy in the context of patient and family needs. J. Am. Geriatr. Soc., v.51, n. p.89-95, 2003.
13. GIACOBINI, E. Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications. Neurochem. Int., v.32, n.5-6, p.413-419, 1998.
14. HASHIMOTO, M.; ROCKENSTEIN, E.; CREWS, L.; MASLIAH, E. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromolecular. Med., v.4 , n.1-2, p.21-36, 2003.
15. HOLZGRABE, U.; KAPKOVA, P.; ALPTUZUN, V.; SCHEIBER, J.; KUGELMANN, E. Targetting acetylcholinesterase to treat neurodegeneration. Expert Opin. Ther. Targets, v.11, n.2, p.161-179, 2007.
16. ITOH, J.; NABESHIMA, T.; KAMEYAMA, T. Utility of an elevated plus maze for the evaluation of nootropics, scopolamine and electro convulsive shock. Psychopharmacology, v.101, n. p.27-33, 1990.
17. IZZO, A.A.; CAPASSO, F. Herbal medicines to treat Alzheimer's disease. Trends Pharmacol. Sci., v. 28, n.2, p.47-48, 2007.
18. JOSHI, H.; PARLE, M. Antiamnesic effects of Desmodium gangeticum in mice. Yakugaku Zashshi, v. 126, n.2, p.14-17, 2006.
19. JOSHI, H.; PARLE, M. Effects of piperine on memory and behavior mediated via monoamine neurotransmitters. J. Trad. Med., v. 2, n. p. 39-43, 2005a.
20. JOSHI, H.; PARLE, M. Evaluation of nootropic potential of Ocimum Sanctum Linn. in mice. Ind. J. Expt. Biol., v.44, n. p.133-136, 2006a.
21. JOSHI, H.; PARLE, M. Nardostachys jatamansi improves learning and memory in mice. J. Med. Food, v. 9, n.1, p. 113-118, 2006b.
22. JOSHI, H.; PARLE, M. Evaluation of the antiamnesic effects of Phyllanthus niruri in mice. Colomb. Med., v.38, n.2, p. 132-139, 2007a.
23. JOSHI, H.; PARLE, M. Antiamnesic potentials of Foeniculum vulgare Linn. in mice. The Oriental Pharmacy and Experimental Medicine, v.7, n.2, p. 121-129, 2007b.
24. JOSHI, H.; PARLE, M. Management of dementia through ayurvedic formulation brahmi rasayana BR-2T in mice. Alzheimers Dement., v.1, n.7, p. 64, 2005b.
25. JOSHI, H.; Soumya, S.V.; Chauhan, J. Pharmacological evidences for Anti-Alzheimer's potentials of Sesbania grandiflora in mice. Natural Products, v.3, n.3, p. 112-118, 2007c.
26. JAY, M.E. Cholinesterase inhibitors in the treatment of dementia. JAOA, v. 3, n. p. 145-158, 2005.
27. KERR. M.; SMALL, D. Cytoplasmic domain of the betaamyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development. J. Neurosci. Res., v. 80, n.2, p. 151-159, 2005.
28. LEOPALDO, L.S.; MARIA, A.V.T.; PATRICIA, M.; GUSTAVO, A.S. The use of herbal medicines in Alzheimer's disease- A systematic review. eCAM, v. 3, n.34, p. 441-445, 2006.
29. LUCHSINGER, J.A.; TANG, M.X.; MILLER, J.; GREEN, R.; MAYEUX, R. Relation of higher folate intake to lower risk of Alzheimer's disease in elderly. Arch Neurol., v. 64(1), p. 86-92, 2007.
30. MCKEITH, I.G.; BURNS, D.J.; BALLARD, C.G.; COLLERTON, D.; JARROS, E.; MORRIS, C.M. Dementia with lewy bodies. Semin. Clin. Neuropsychiatry, v.51, p. 296-304, 2003.
31. NADKARNI, A.K. Indian Materia Medica. Popular Prakashan.Bombay; 1976.
32. NEWMAN, M.; MUSGRAVE, F.I.; LARDELLI, M. Alzheimer's disease: Amyloidgenesis the presenilins and animal models. Biochem Biophys Acta, v.1772, p.285-297, 2007.
33. PARLE, M.; DHINGRA, D. Ascorbic acid: a promising memory enhancer in mice. J. Pharmacol. Sci, v. 93, n. p. 129-135, 2003.
34. PARLE, M.; DHINGRA, D.; KULKARNI, S.K. Improvement of mouse memory by Myristica fragrans seeds. J. Med. Food, v. 7, p. 157-161, 2004.
35. POIRIER, J. Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action. Int. J. Clin. Pract. Suppl., v. 127, p. 6-19, 2002.
36. RAJASEKARAN, A; PONNUSAMY, K. Antifungal activity of Clerodendron. Inerme (L) and Clerodendron. Phlomidis (L). Turk. J. Biol., v.30, n. p.139-142, 2006.
37. RANI, S.; AHAMED, N.; RAJARAM, S.; SALUJA, R.; THENMOZHI, S.; MURUGESAN, T. Anti-diarrhoeal evaluation of Clerodendrum phlomidis Linn.leaf extract in rats. J. Ethnopharmacol., v.68, n. p.315-319, 1999.
38. ROY, R.; PANDEY, V.B. Achalcone glycoside from Clerodendron phlomidis. Phytochemistry, v.37, n.6, p.1775-6, 1994.
39. SCATENA, R.; MARTORONA, G.E.; BOTTANI, P.; BOTTA, G.; PASTOVE, P.; GIARDINA, B. An update of pharmacological approaches to neurodegenerative diseases. Expert Opin. Investig. Drugs, v. 16, n.1, p.59-72, 2007.
40. SJOGREN, M.; MIELXE, M.; GUSTAFSON, D.; ZANDI, P.; SKOOG, I. Cholesterol and Alzheimer's disease - is there a relation. Mech. Ageing. Dev., v.127, n.2, p.138-47, 2006.
41. SUDHA, S.; MADEPALLI, K.; LAKSHMANA.; PRADHAN, N. Chronic phenytoin induced impairment of learning and memory with associated changes in brain acetyl cholinesterase activity and monoamine levels. Pharmacol. Biochem. Behav., v.52, n. p.119-124, 2001.
42. TOHGI, H.; ABE, T.; KIMURA, M.; SAHEKI, M.; TAKAHASHI, S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer type dementia. J. Neural. Transm., v. 103, n. p. 1211-1220, 1990.
43. YAARI, R.; COREY-BLOOM, J. Alzheimer's disease. Semin. Neurol., v. 27, n.1, p. 32-41, 2007.